Productivity Rankings is a unique service offered only by “AD Scientific Index”. This is a ranking system derived from the i10 index in order to show the productivity of the scientist in publishing scientific articles of value. Productivity Rankings is an instrument that lists productive scientists in a given area, discipline, university, and country and can guide the development of meaningful incentives and academic policies. The world rankings, regional rankings, and university rankings of scientists in this table are developed based on the total i10 index. Click for "last 6 years' i10 index". Also see: Universities Rankings 2024 (Sort by : Total i10 Index) and Universities Rankings 2024 (Sort by : Last 6 Years i10 Index)
Total i10 Index | AD Scientific Index - World Scientists i10 Productivity Rankings - 2024 | i10 Index Metrics | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
University Rank | Country Rank | Region Rank | World Rank | Name | Country | University / Institution |
Subject Research Areas |
Total | Last 6 Year | Last 6 year/total |
7 | 372 | 41,111 | 215,498 |
![]() |
![]() |
Others
|
61 | 48 | 0.787 | |
8 | 379 | 42,026 | 219,806 |
![]() |
![]() |
Others
Diagnostics | microarray | biosensor | shrimp | |
60 | 48 | 0.800 | |
13 | 471 | 49,655 | 256,530 |
![]() |
![]() |
Others
Drug resistant tuberculosis | |
53 | 31 | 0.585 | |
16 | 632 | 62,227 | 314,988 |
![]() |
![]() |
Others
Microbial lipid | Bioprocessing | |
44 | 28 | 0.636 | |
19 | 722 | 69,213 | 347,751 |
![]() |
![]() |
Others
Molecular Virology | Vaccine development | |
40 | 26 | 0.650 | |
24 | 794 | 74,783 | 372,780 |
![]() |
![]() |
Others
Malaria | Drug discovery | Genetic engineering | |
37 | 31 | 0.838 | |
33 | 1,119 | 98,955 | 481,606 |
![]() |
![]() |
Others
|
28 | 23 | 0.821 | |
42 | 1,372 | 115,622 | 557,573 |
![]() |
![]() |
Others
QTL mapping | drought resistance in rice | aerobic rice | nitrogen use efficiency | |
23 | 23 | 1.000 | |
43 | 1,415 | 118,223 | 568,357 |
![]() |
![]() |
Others
Translational research | |
23 | 16 | 0.696 | |
45 | 1,441 | 119,889 | 576,837 |
![]() |
![]() |
Others
|
22 | 22 | 1.000 | |
![]() |
Click for INSTITUTIONAL BULK REGISTRATION and PREMIUM MEMBERSHIP advantages |
![]() |
||||||||
46 | 1,542 | 126,208 | 604,242 |
![]() |
![]() |
Others
|
21 | 17 | 0.810 | |
47 | 1,549 | 126,417 | 605,006 |
![]() |
![]() |
Others
Actinomycetes | |
21 | 17 | 0.810 | |
50 | 1,604 | 129,869 | 620,705 |
![]() |
![]() |
Others
Metabolic engineering | synthetic biology | biofuels | microbiology | |
20 | 18 | 0.900 | |
52 | 1,671 | 133,869 | 638,881 |
![]() |
![]() |
Others
Speciation | Diversification | Adaptation | |
19 | 19 | 1.000 | |
54 | 1,751 | 138,928 | 661,495 |
![]() |
![]() |
Others
Fungal biology | Biorefinery | Enzyme technology | |
18 | 18 | 1.000 | |
56 | 1,778 | 140,347 | 666,369 |
![]() |
![]() |
Others
Probiotics | Gut microbiome | Functional foods | |
18 | 17 | 0.944 | |
58 | 1,791 | 141,294 | 670,377 |
![]() |
![]() |
Others
Protein - protein interactions of host and pathogen | Fish vaccine development | |
18 | 15 | 0.833 | |
59 | 1,802 | 141,754 | 672,332 |
![]() |
![]() |
Others
|
18 | 14 | 0.778 | |
60 | 1,837 | 144,398 | 685,642 |
![]() |
![]() |
Others
Molecular Entomology | arthropod-borne disease | vector-borne disease | mosquito | arbovirus | |
17 | 17 | 1.000 | |
61 | 1,865 | 146,326 | 692,879 |
![]() |
![]() |
Others
|
17 | 15 | 0.882 | |
71 | 2,120 | 161,003 | 755,456 |
![]() |
![]() |
Others
Biorefinery enzymes | Yeast cell surface display | Strain improvement | Bioprocess optimization | |
15 | 10 | 0.667 | |
72 | 2,185 | 164,905 | 772,076 |
![]() |
![]() |
Others
Shrimp Immunology and infectious disease | Shrimp Vaccination | The molecular mechanism of shrimp survived WSSV infection | |
14 | 13 | 0.929 | |
76 | 2,454 | 179,370 | 831,498 |
![]() |
![]() |
Others
Fungal Genetics and Biology | Multiomic Application in Enzyme Technology | |
12 | 12 | 1.000 | |
78 | 2,526 | 183,654 | 846,897 |
![]() |
![]() |
Others
|
12 | 9 | 0.750 | |
79 | 2,533 | 183,825 | 847,697 |
![]() |
![]() |
Others
Influenza A | SARS-CoV-2 | antiviral drug screening | |
12 | 8 | 0.667 |